SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024097
Filing Date
2016-08-11
Accepted
2016-08-11 17:13:27
Documents
41
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20160630.htm 10-Q 1143995
2 EX-31.1 reta-ex311_9.htm EX-31.1 19035
3 EX-31.2 reta-ex312_8.htm EX-31.2 18958
4 EX-32.1 reta-ex321_7.htm EX-32.1 10256
5 EX-32.2 reta-ex322_6.htm EX-32.2 10241
6 GRAPHIC gnn2fsnmpvdg000001.jpg GRAPHIC 27536
  Complete submission text file 0001564590-16-024097.txt   2865282

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT reta-20160630.xml EX-101.INS 381832
8 XBRL TAXONOMY EXTENSION SCHEMA reta-20160630.xsd EX-101.SCH 19248
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20160630_cal.xml EX-101.CAL 27173
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20160630_def.xml EX-101.DEF 52309
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20160630_lab.xml EX-101.LAB 165277
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20160630_pre.xml EX-101.PRE 124902
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 161825431
SIC: 2834 Pharmaceutical Preparations